SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-12
DOI
10.1038/s41379-019-0303-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary
- (2019) Yibo Xue et al. Nature Communications
- SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer
- (2019) Yibo Xue et al. Nature Communications
- NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma
- (2018) Sarah Chiang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The SWI/SNF complex subunit genes: Their functions, variations, and links to risk and survival outcomes in human cancers
- (2018) Sevtap Savas et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Frequent loss of claudin-4 expression in dedifferentiated and undifferentiated endometrial carcinomas
- (2018) Basile Tessier-Cloutier et al. HISTOPATHOLOGY
- Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade
- (2018) Petar Jelinic et al. JNCI-Journal of the National Cancer Institute
- Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
- (2018) Antoine Italiano et al. LANCET ONCOLOGY
- SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma
- (2018) David L. Kolin et al. MODERN PATHOLOGY
- A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal
- (2018) James X. Sun et al. PLoS Computational Biology
- Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade
- (2018) Petar Jelinic et al. JNCI-Journal of the National Cancer Institute
- SMARCA4-deficient Thoracic Sarcomas
- (2018) Raul Perret et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
- (2018) Nicholas C. Turner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent advances in the histological and molecular classification of endometrial stromal neoplasms
- (2018) Joana Ferreira et al. VIRCHOWS ARCHIV
- Comprehensive genomic profiling reveals inactivating SMARCA4 mutations and low tumor mutational burden in small cell carcinoma of the ovary, hypercalcemic-type
- (2017) Douglas I. Lin et al. GYNECOLOGIC ONCOLOGY
- SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior
- (2017) Jennifer L Sauter et al. MODERN PATHOLOGY
- Claudin-4 expression distinguishes SWI/SNF complex-deficient undifferentiated carcinomas from sarcomas
- (2017) Inga-Marie Schaefer et al. MODERN PATHOLOGY
- Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models
- (2017) Elayne Chan-Penebre et al. MOLECULAR CANCER THERAPEUTICS
- SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1neg/CK7pos/HepPar-1pos immunophenotype
- (2017) Abbas Agaimy et al. VIRCHOWS ARCHIV
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
- (2017) Zachary R. Chalmers et al. Genome Medicine
- Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting
- (2016) J. He et al. BLOOD
- Immunophenotypic features of dedifferentiated endometrial carcinoma - insights from BRG1/INI1-deficient tumours
- (2016) Lien N Hoang et al. HISTOPATHOLOGY
- Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program
- (2016) Raushan T. Kurmasheva et al. PEDIATRIC BLOOD & CANCER
- 302 A phase 1 study of EPZ-6438 (E7438), an Enhancer of Zeste-Homolog 2 (EZH2) inhibitor: Preliminary activity in INI1-negative tumors
- (2015) A. Italiano et al. EUROPEAN JOURNAL OF CANCER
- Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type
- (2015) Anthony N Karnezis et al. JOURNAL OF PATHOLOGY
- The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses
- (2015) Lifang Zhang et al. Molecular Cancer
- SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas
- (2015) Francois Le Loarer et al. NATURE GENETICS
- Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
- (2015) Nicholas C. Turner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Familial rhabdoid tumour 'avant la lettre'-from pathology review to exome sequencing and back again
- (2013) Leora Witkowski et al. JOURNAL OF PATHOLOGY
- Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature
- (2013) Diana M Haninger et al. MODERN PATHOLOGY
- Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
- (2013) Garrett M Frampton et al. NATURE BIOTECHNOLOGY
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
- (2012) Doron Lipson et al. NATURE MEDICINE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Nonsense Mutation and Inactivation of SMARCA4 (BRG1) in an Atypical Teratoid/Rhabdoid Tumor Showing Retained SMARCB1 (INI1) Expression
- (2011) Martin Hasselblatt et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Germline Nonsense Mutation and Somatic Inactivation of SMARCA4/BRG1 in a Family with Rhabdoid Tumor Predisposition Syndrome
- (2010) Reinhard Schneppenheim et al. AMERICAN JOURNAL OF HUMAN GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started